Held at the ICC, Birmingham, from the 11th to the 13th of November, conference attendees will be invited into a virtual ward, where representatives from Cepheid will be on hand to take samples for determination of MRSA and MSSA nasal carriage status. Visitors to this interactive suite will also have the opportunity to view the Company’s GeneXpert® GX-II automated diagnostic instrument, part of the GeneXpert range of fully scalable, molecular diagnostic workstations.
Cepheid will also be showcasing the larger, 16-module configuration GeneXpert GXXVI, providing a comprehensive demonstration of the system’s capabilities. This system will be used to perform live testing of delegate samples with the Xpert® SA Nasal Complete rapid test, delivering sensitive and accurate results in just over an hour. The recently launched Winter Care Bundle, which also includes the Xpert Norovirus, Xpert C. difficile and Xpert Flu tests, will be highlighted, backed by a wealth of technical information, including abstracts describing the evaluation of the clinical performance of the Xpert Flu test and the development and comparative evaluation of Xpert Norovirus.
For more information, visit Cepheid at Booth #44 or go to www.cepheidinternational.com
About Cepheid
Based in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy to-use molecular systems and tests. By automating highly complex and time consuming manual procedures, the company’s solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit http://www.cepheid.com.
_________________________________________________
Cepheid to offer live MRSA testing at FIS 2013
8 November 2013
Cepheid, a senior sponsor of the Federation of Infection Societies (FIS) Action on Infection conference and exhibition, will be offering live MRSA testing to visitors to its exhibition stand at Booth #44.